Frontlight ResearchEarly access
Rheumatoid arthritis trials in Czechia
3 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Where
- Hlučín, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- AbbVie
See details and how to joinNCT06972446 · EU 2025-520721-21-00 - Phase 2Not yet taking people in CzechiaA study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
- Where
- Moravska Ostrava A Privoz, Prague, Prague 2, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 95 worldwide
- Run by
- Elevara Medicines Limited
See details and how to join2025-524005-32-00 - Phase 1Taking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Prague, Prague 2
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00